论文部分内容阅读
目的总结阿奇霉素联合特步他林雾化吸入用于小儿支原体肺炎的疗效。方法筛选2015年01月至2016年01月在我院接受救治的小儿支原体肺炎患者共70例,分成两组:治疗组(n=36例,施以阿奇霉素联合特步他林雾化吸入),常规组(n=34例,施以常规药物),对两组在小儿支原体肺炎中的应用效果进行对照。结果治疗后,治疗组有效率94.44%优于常规组76.47%(P<0.05)。结论在小儿支原体肺炎患者治疗中,施以阿奇霉素联合特步他林雾化吸入,有助于提升其临床疗效,具有较高的临床应用价值。
Objective To summarize the efficacy of azithromycin combined with tebutrine inhalation for mycoplasma pneumonia in children. Methods Seventy patients with mycoplasma pneumonia who were treated in our hospital from January 2015 to January 2016 were divided into two groups: treatment group (n = 36, aerosolized with azithromycin combined with tebutrine), conventional Group (n = 34, with conventional drugs), the effect of the two groups in children with mycoplasma pneumonia were compared. Results After treatment, the effective rate of the treatment group was 94.44%, which was significantly higher than that of the conventional group (76.47%, P <0.05). Conclusion In the treatment of children with mycoplasma pneumonia, azithromycin combined with tebutrine inhalation, help to enhance its clinical efficacy, with high clinical value.